36C26125Q0353.pdf

PAGE 1 OF 1. REQUISITION NO.

2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE 4. ORDER NO. 5. SOLICITATION NUMBER 6. SOLICITATION ISSUE DATE

a. NAME b. TELEPHONE NO. (No Collect Calls) 8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY CODE 10. THIS ACQUISITION IS UNRESTRICTED OR SET ASIDE: % FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ IFB RFP

15. DELIVER TO CODE 16. ADMINISTERED BY CODE

17a. CONTRACTOR/OFFEROR CODE FACILITY CODE 18a. PAYMENT WILL BE MADE BY CODE

TELEPHONE NO. UEI: EFT:

PHONE: FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19. 20. 21. 22. 23. 24.

ITEM NO. SCHEDULE OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA 26. TOTAL AWARD AMOUNT (For Govt. Use Only)

27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA ARE ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA ARE ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________ 29. AWARD OF CONTRACT: REF. ___________________________________ OFFER

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND DATED ________________________________. YOUR OFFER ON SOLICITATION

DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE

ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)

30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION (REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

36C261-25-AP-0375

612-25-2-111-0032

36C26125Q0353 03-12-2025

LaDonna Collins | ladonna.collins@va.gov 719-203-8675 03-21-2025

3:30PM PDT

Department of Veterans Affairs

Network Contract Office (NCO 21)

X

621511

$41.5 Million

N/A

"See Delivery Schedule"

Network Contracting Office (NCO 21)

FMS-VA-2(101) Financial Services Center

PO Box 149971

Austin TX 78714-9971

The contractor shall provide laboratory testing services to

Sacramento VA Medical Center Pathology and Laboratory IAW the attached performance work statement (PWS).

Period of Performance:

Base plus four (4) optional years.

Written questions will be accepted until 12 noon PST

Tuesday, March 18, 2025. Verbal questions will not be accepted.

Quotes are due no later than 3:30 PM, Pacific Time, Friday, March 21, 2025, to ladonna.collins@va.gov.

LaDonna Collins

36C26125Q0353

Table of Contents

SECTION A

A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

B.2 PRICE/COST SCHEDULE

SECTION C - CONTRACT CLAUSES

C.1 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

C.2 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (NOV 2023)

ADDENDUM to FAR 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES

C.3 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT

STATUTES OR EXECUTIVE ORDERS—COMMERCIAL PRODUCTS AND COMMERCIAL

SERVICES (JAN 2025)

C.4 52.217-8 OPTION TO EXTEND SERVICES (NOV 1999)

C.5 52.217-9 OPTION TO EXTEND THE TERM OF THE CONTRACT (MAR 2000)

C.6 VAAR 852.203-70 COMMERCIAL ADVERTISING (MAY 2018)

C.7 VAAR 852.215-70 SERVICE-DISABLED VETERAN-OWNED AND VETERAN-OWNED

SMALL BUSINESS EVALUATION FACTORS (JAN 2023) (DEVIATION)

C.8 VAAR 852.215-71 EVALUATION FACTOR COMMITMENTS (OCT 2019)

C.9 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (NOV 2018)

C.10 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020)

SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS

SECTION E - SOLICITATION PROVISIONS

E.1 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB 1998)

E.2 52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS AND

VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (NOV 2021)

E.3 52.204-29 FEDERAL ACQUISITION SUPPLY CHAIN SECURITY ACT ORDERS—

REPRESENTATION AND DISCLOSURES (DEC 2023)

E.4 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (SEP 2023)

ADDENDUM to FAR 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES

E.5 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

(NOV 2021)

ADDENDUM to 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL

SERVICES

E.6 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES (MAY 2024)

E.7 52.216-1 TYPE OF CONTRACT (APR 1984)

E.8 VAAR 852.201-70 CONTRACTING OFFICER'S REPRESENTATIVE (DEC 2022)

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR:

b. GOVERNMENT: Contracting Officer 36C261

Network Contract Office (NCO 21)

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

[X] 52.232-33, Payment by Electronic Funds Transfer—System for Award Management, or

[] 52.232-36, Payment by Third Party

3. INVOICES: Invoices shall be submitted in arrears:

a. Quarterly []

b. Semi-Annually []

c. Other [X] MONTHLY IN ARREARS

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment

Requests.

Invoicing shall be in accordance with the requirements of The Department of Veterans Affairs Financial

Services Center (VAFSC). The latest information shall be used for invoicing and payments and may change during the period of performance of this acquisition. Current invoicing information is located at http://www.fsc.va.gov/einvoice.asp.

ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the

Solicitation numbered and dated as follows:

AMENDMENT NO DATE

http://www.fsc.va.gov/einvoice.asp

B.2 PRICE/COST SCHEDULE

ITEM

NUMBER

DESCRIPTION OF

SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

3.00 EA __________________ __________________

SCA3 (MJD/ATXN3) Repeat Expansion

Test

Contract Period: Base POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories PRODUCT/SERVICE CODE: Q301 - Medical - Reference Laboratory Testing

2.00 EA __________________ __________________

Alzheimer's Evaluation

Contract Period: Base POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Early Onset Alzheimer's Evaluation

POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

1.00 EA __________________ __________________

C9ORF72 (FTD) DNA Test

POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Frontotemporal Dementia (FTD)

Evaluation

Contract Period: Base POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

OMPD Repeat Expansion Test

Contract Period: Base POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

SCA1 (ATXN1) Repeat Expansion Test

POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

C9orf72 DNA Test

POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

SCA2 (ATXN2) Repeat Expansion Test

POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Hemiplegic Migraine Sequencing

Evaluation

Contract Period: Base POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

CMT Advanced Evaluation

- Comprehensive

Contract Period: Base POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

SMA Diagnostic Test

POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

SMA Plus

POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

CASPR2 Autoantibody Test (Epilepsy)

POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Leukoencephalopathy with Vanishing

White Matter

Contract Period: Base POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Amyotrophic Lateral Sclerosis

Advanced Evaluation

Contract Period: Base POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Atypical Spinal Muscular Atrophy

Advanced Sequencing Evaluation

POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

PKD1 DNA Sequencing and Deletion

Evaluation

Contract Period: Base POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Complete PKDx Evaluation

POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

PKD2 DNA Sequencing and Deletion Evaluation

POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

PKD2 DNA Sequencing Test

POP End: 03-31-2026 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Test

Contract Period: Option 1 POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Contract Period: Option 1 POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Contract Period: Option 1 POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Frontotemporal Dementia (FTD) Evaluation

POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Evaluation

Contract Period: Option 1 POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

- Comprehensive

Contract Period: Option 1 POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2027

POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

White Matter

Contract Period: Option 1 POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Advanced Evaluation

Contract Period: Option 1 POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Advanced Sequencing Evaluation

Contract Period: Option 1 POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Evaluation

Contract Period: Option 1 POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

PKD2 DNA Sequencing and Deletion

Evaluation

Contract Period: Option 1 POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2027 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Test

Contract Period: Option 2 POP Begin: 04-01-2027 POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Contract Period: Option 2 POP Begin: 04-01-2027 POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2028

POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Evaluation

Contract Period: Option 2 POP Begin: 04-01-2027 POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2028

Evaluation

Contract Period: Option 2 POP Begin: 04-01-2027 POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

- Comprehensive

Contract Period: Option 2 POP Begin: 04-01-2027 POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

White Matter

Contract Period: Option 2 POP Begin: 04-01-2027 POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Advanced Evaluation

Contract Period: Option 2 POP Begin: 04-01-2027 POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Advanced Sequencing Evaluation

Contract Period: Option 2 POP Begin: 04-01-2027 POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Evaluation

Contract Period: Option 2 POP Begin: 04-01-2027 POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Evaluation

Contract Period: Option 2

POP End: 03-31-2028

POP End: 03-31-2028 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Test

Contract Period: Option 3 POP Begin: 04-01-2028 POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Contract Period: Option 3 POP Begin: 04-01-2028 POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Evaluation

POP Begin: 04-01-2028 POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Evaluation

Contract Period: Option 3 POP Begin: 04-01-2028 POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

- Comprehensive

Contract Period: Option 3 POP Begin: 04-01-2028 POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

White Matter

Contract Period: Option 3 POP Begin: 04-01-2028 POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Advanced Evaluation

Contract Period: Option 3 POP Begin: 04-01-2028 POP End: 03-31-2029

Advanced Sequencing Evaluation

Contract Period: Option 3 POP Begin: 04-01-2028 POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Evaluation

Contract Period: Option 3 POP Begin: 04-01-2028 POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Evaluation

Contract Period: Option 3 POP Begin: 04-01-2028 POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2029 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Test

Contract Period: Option 4 POP Begin: 04-01-2029 POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Contract Period: Option 4 POP Begin: 04-01-2029 POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Evaluation

Contract Period: Option 4 POP Begin: 04-01-2029 POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2030

POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Evaluation

Contract Period: Option 4 POP Begin: 04-01-2029 POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

- Comprehensive

Contract Period: Option 4 POP Begin: 04-01-2029 POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

White Matter

Contract Period: Option 4 POP Begin: 04-01-2029 POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Advanced Evaluation

Contract Period: Option 4 POP Begin: 04-01-2029 POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Advanced Sequencing Evaluation

Contract Period: Option 4 POP Begin: 04-01-2029 POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Evaluation

Contract Period: Option 4 POP Begin: 04-01-2029 POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

Evaluation

Contract Period: Option 4 POP Begin: 04-01-2029 POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

POP End: 03-31-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories

GRAND TOTAL __________________

PERFORMANCE WORK STATEMENT

1. Background The Sacramento VA Medical Center (VAMC) needs reference lab services to perform genetic testing for various neurologic disorders such as Alzheimer's disease, muscular dystrophy, and other neuromuscular and developmental disorders. These tests are essential for diagnosing conditions related to neurology, endocrinology, nephrology, hearing loss, Charcot-Marie-Tooth disease, and whole genome microarrays. They provide diagnoses for peripheral nerve disorders, neurogenetic disorders, Alzheimer's disease, paraneoplastic syndromes, movement disorders, neuromuscular disorders, and ataxia.

2. Scope All work is to be performed at the reference laboratory for lab tests requested by the Sacramento VAMC, Pathology and Laboratory Medicine (PLMS) Department. The period of performance for this service contract is a base period plus 4 option years.

3. Specific Tasks The Reference Laboratory shall provide in accordance with all applicable federal, state, and local regulations, laws, and ordinances, and in accordance with the specifications outlined for accreditation certification if applicable, patient specimen testing to identify neurologic disorders. Quantities of tests will depend upon patient specifics. (See table listing specific tests)

TEST DESCRIPTION TEST CODE

SCA3 (MJD/ATXN3) Repeat Expansion Test 105

Alzheimer's Evaluation 178

Early Onset Alzheimer's Evaluation 179

C9ORF72 (FTD) DNA Test 209

Frontotemporal Dementia (FTD) Evaluation 281

OMPD Repeat Expansion Test 300

SCA1 (ATXN1) Repeat Expansion Test 371

C9orf72 DNA Test 670

SCA2 (ATXN2) Repeat Expansion Test 672

Hemiplegic Migraine Sequencing Evaluation 1148

CMT Advanced Evaluation - Comprehensive 4001

SMA Diagnostic Test 5026

SMA Plus 5070

CASPR2 Autoantibody Test (Epilepsy) 5103

Leukoencephalopathy with Vanishing White Matter 6106

Amyotrophic Lateral Sclerosis Advanced Evaluation 6520

Atypical Spinal Muscular Atrophy Advanced Sequencing Evaluation 6521

PKD1 DNA Sequencing and Deletion Evaluation 8101

Complete PKDx Evaluation 8101

PKD2 DNA Sequencing and Deletion Evaluation 8102

PKD2 DNA Sequencing Test 8104

The Contractor shall provide routine test results to Sacramento VAMC within twenty-four (24) hours following test completion, except when specimens are picked up the day before a weekend or holiday (in which case the results will be provided the following business day) and for tests with published longer turnaround times.

Specimen Preparation and Storage for Reference Testing Specimens

Contractor shall supply each Government facility with its commercial laboratory reference test manual to ensure that the collection and storage of specimens are in accordance with Contractor’s requirements.

Contractor shall provide all materials necessary to collect and preserve specimens that are destined to the commercial reference laboratory for testing. These materials include those items that are dictated by and in compliance with the collection requirements of the commercial reference laboratory.

If a medico legal specimen is submitted, the Contractor shall provide its own special forms and special handling procedures to maintain a valid “chain-of-custody possession” and develop the formal documentation necessary for that purpose. Contractor’s testing personnel who performed the analysis may be required to provide Court testimony. Contractor testimony shall be provided as required at no additional expense to the Government.

Contractor shall be responsible for storing specimens in such a manner to ensure the integrity of the specimen.

Transportation Services for Reference Testing Specimens

Contractor shall provide transportation of primarily biomedical materials that include patient specimens and microbiology cultures and stocks, originating from Government facilities and destined to the contracted commercial reference laboratory. These items are classified as Hazard Materials Class 6, Division 6.2 and are defined in 49 CFR Part 173.134 as those materials that contain or could contain etiologic agents. Transportation shall be done in such a manner that the safety and integrity of the biomedical material is maintained.

Routine transportation services shall occur once per day from the Government facilities. Specimen pick-up times will be negotiated after contract award.

Contractor shall provide all necessary supplies for biomedical materials to be transported from the originating facility to the Contractor’s laboratory. These supplies shall include, but may not be limited to:

Shipping and packaging containers. Packing material must be capable of maintaining temperature requirements for specimens until they reach the Contractor’s laboratory.

Required labels and packaging materials for shipping specimens via courier that are infectious, or etiologic agents, in accordance with appropriate requirements of 42 CFR Part 72, 49 CFR Parts 171 and 173, and the Dangerous Goods Regulations of the International Air Transport Association (IATA) consistent with current regulatory updates.

Test request forms, preprinted with the appropriate Shipping Section details and account information.

Test request forms for specialized testing (e.g., cytogenetics and tissue).

Emergency transportation services shall be available 24 hours per day, seven days per week including Government holidays. The estimated number of emergency transportations per facility per year is one (1). Response time for emergency transportation services shall be within 4 hours for Mather VA Medical Centers. Emergency response time refers only to the transportation of the specimen(s) and does not include the time for test performance.

Specimen Testing

The Contractor shall provide the full range of clinical and anatomic pathology diagnostic testing capabilities to execute all required tests as annotated in Attachment A. Contractor shall make available the following test information:

Requisition form requirements Alphabetized test name list Test order code

Specimen collection and preservation requirements Test method employed (indicate if testing performed in duplicate) and interpretations Test reference intervals adjusted for age, sex, or race, when required Test specific sensitivity, specificity, and interferences, when required Result code Test critical values if any Policy for critical value notification CPT coding

Test turnaround times (minimum and maximum times indicated); where the turnaround time is defined as the time between receipt of specimen by the Contractor and receipt of results by a government facility.

Schedule of test performance (specific days of week indicated)

Location of test performance by test name (i.e., name of primary laboratory, name of separate branch/division of primary lab, name, and address of secondary (sub-contracted) laboratory must be cited)

The Contractor shall notify the Contracting Officer and each Government facility of any test information modifications no later than two weeks prior to the implementation date of the test change.

Additional tests may be added to the contract through modification by the Contracting Officer.

All reference laboratory testing shall be executed in accordance with standard industry practices. It is preferred that test methods are FDA approved. Any non-FDA approved method being performed shall have a disclaimer and documented validation plan. Upon request, the validation plan and validation results shall be made available to the COR or designee.

The Contractor shall ensure the accurate and timely performance of laboratory testing services on the biomedical materials.

Specimen Retention

A medico legal specimen shall be retained indefinitely. This type of specimen will be identified by the Government in writing or through telephone communication.

All anatomic pathology materials (e.g., histology blocks, slides, or other diagnostic material) generated by the VA and sent to the Contractor laboratory for testing and diagnostic evaluation shall be returned within 7 days after final diagnosis is reported.

Reporting of Results

The results of testing shall be reported within the prescribed turnaround times provided by the Contractor as part of the test information.

A report of laboratory testing results must be transmitted as a printed copy to the dedicated printer at the ordering Government facility and when possible, through electronic host to host computer interface. Electronic delivery of reports by computer interface connection is normally the required method of receipt. However, in unusual circumstances where electronic delivery via the dedicated printer is not possible, the Contractor shall deliver the reports without an additional charge by expedited overnight courier shipping, mailing and/or transportation services by hand within 24 hours, or by telephone facsimile to a protected machine identified to the Contractor by the VA.

Delivery by electronic mail i.e., MS Outlook, etc. is prohibited. Specifications outlining the requirements of this computer interface, including computer hardware, maintenance, and supply requirements, are defined in the Telecommunication Requirements below.

Each test report generated in hard copy form or through electronic transmission shall, at minimum, include the following information:

Patient's full name Patient’s identification number, e.g., social security number (SSN) Physician’s name (if supplied) Government laboratory accession number (if supplied) Submitting facility name Submitting facility account number Patient's location (clinic/ward) (if supplied) Test(s) ordered Date/time of specimen collection (when available) Date/time test completed Test result Reference intervals (adjusted for age, sex, or race, when appropriate) Toxic and therapeutic ranges, if applicable Flagged abnormal results Reference laboratory accession number Name and address of testing laboratory Any other information the laboratory has that may indicate a questionable validity of test results Specimen inadequacy with documentation supporting its unsuitability for testing

Test results determined by the contractor to be critical, shall be communicated by telephone to a designated Government contact person(s) at the originating Government laboratory facility upon verification of the critical test result. The telephonic report shall be followed by an electronic transmission.

Contractor Qualifications

Licensing and Accreditation: Contractor shall have and maintain all licenses, permits, accreditation and certificates required by law to operate as a CLIA-certified laboratory. This requirement shall also apply to any subcontractors performing services under this contract.

Contractor shall provide evidence of laboratory accreditation upon receipt of a written request by

VA.

Contractor shall ensure that employees have current and valid professional certifications before providing services under this contract.

The Laboratory Director, medical technologists, medical technicians, and cytotechnologists shall meet personnel qualifications required by CLIA '88 Guidelines.

Pathologists must have graduated from an approved school of medicine or osteopathy and completed a residency or fellowship in pathology acceptable to the United States Surgeons General and must possess a valid license to practice clinical reference laboratory services from a United States jurisdiction.

The Contractor shall maintain current licenses and certificates for all personnel and provide copies of such to V A upon reasonable written request.

The Contractor shall provide evidence of reapplication to the COR of any state license, CLIA certification, or clinical pathology certification 60 days before expiration of license. The Contractor shall provide a copy of the renewed licenses/certificates to the COR prior to expiration.

Customer Service

Contractor shall provide customer service that is accessible by toll-free telephone service 24 hours per day, 7 days per week to assist Government staff for tracking and resolving related issues/problems that may arise in the performance under this contract.

Upon award, the Contractor shall provide the name(s) and telephone number(s) of contractor employees who will address the following customer services throughout the contract performance period:

Telephone Inquiries – Telephone inquiries are divided into four major categories with additional subcategories defining the type of inquiry and the Government’s minimum time expectation for meeting this service.

Specimen Collection

Routine inquiries, questions and clarifications regarding collection requirements shall be addressed at the time of the initial call.

Esoteric inquiries, questions and clarifications regarding collection requirements that require further research shall be addressed within ½ hour of the initial call.

Testing

Inquiries regarding the status of pending orders shall be addressed at the time of the initial call.

Esoteric inquiries when information is requested regarding methodology, correlation, interferences, reflex tests, etc. shall be addressed within two hours of the initial call.

Technical Expertise

Test utilization inquiries where information is required as to the most appropriate test to be ordered shall be addressed within two business hours of initial call.

Result interpretation inquiries shall be addressed within four business hours of initial call.

Consultative services where information is required regarding the clinical significance of tests shall be addressed within twenty-four business hours of the initial call.

Account follow-up Information general in nature yet specific to the account, e.g., test pricing, equipment repair, supply ordering, etc. shall be addressed within four hours of the initial call.

The Contractor shall notify the originating laboratory by telephone of specimens cancelled due to unacceptability for reasons relating to volume, specimen container, identification, loss of specimen, etc.

The Government will place orders for specimen collection and transportation supplies by telephone or through written or electronic methods.

Consultative Services/Utilization Reports

Contractor shall prove consultative services that are consistent with the services offered to other contracted customers without compensation. These services may include consultations by laboratory professionals or experienced physicians on test or methodology selection or test result interpretation.

Contractor shall provide a statistical analysis of the Government facilities’ workload testing volumes to assist in the monitoring of ordering trends and utilization patterns and will make recommendations to the facilities on mechanisms to reduce their costs.

Contractor shall provide monthly a cumulative workload summary report of tests performed. The summary must include the facility account number, the test name, the test ordering code, monthly test volume, year-to-date test volume, unit test cost, monthly test expenditures and year-to date test expenditures.

A copy of the report shall be delivered electronically to the Contracting Officer, Lead COR, and/or each Government facility COR by the 10th of the month following the close of the reporting month.

All reports shall be submitted in electronic spreadsheet format and have the capability to sort by four (4) different methods:

Facility account number Test names listed alphabetically Test names listed in order of year-to-date test frequency (highest to lowest) Test names listed in order of year-to-date total test cost (highest to lowest)

Contractor shall provide a monthly listing of any tests performed not listed in Attachment A. This listing shall include, at a minimum, the test name and/or test ordering code, quantity of each test performed, and the FSS contract pricing or proposed pricing.

Contractor shall provide a monthly listing of any tests listed in Attachment A that are no longer performed by contractor and shall be removed from Attachment A. This listing shall include, at a minimum, test name and/or test ordering code.

Data Management System

Contractor shall provide to the Government all necessary laboratory test parameters (parameters are required for each test contained in a panel) to insure accurate test result transmission between the Government and the Contractor’s database. Required test parameters include:

• Ordering code

• LOINC code

• CPT code

• Interface code

• Test cost

• Reference ranges

• Units of measurement

• Test result interpretation or interpretive remarks, if appropriate

• Testing site (if not performed at the vendor’s main laboratory facility

• Test methodology

• Specimen types

• Specimen collection and handling requirements

Indication whether test is a panel/profile test, list of tests included in panel/profile

The parameters for all tests in the Contractor’s database shall be kept current and be available to the Government sites throughout the performance period of the contract. Updates to the test parameter information must be provided to Government sites no less than 2 weeks prior to the implementation of any changes. The Contractor shall provide telephone access to a Contractor’s technical representative to respond to any question(s) regarding the laboratory test parameter information.

The Contractor shall provide a data management system that meets the following requirements:

Test ordering must be accomplished through a menu that is intuitive, has minimal options and uses a mouse or touch screen. Upon selection of the test, the computer shall alert (flag) the user to the type of specimen required and the storage conditions. It must also alert the user to the location of the laboratory that will be performing the test.

Test definition, test information and test requirements must be complete, available, and easily accessible.

Accepts shipping manifests generated that identifies the specimens sent to the commercial reference laboratory, transportation conditions, and testing ordered.

The status and the results of testing must be available within published timeframes and easily retrievable using varying options. At a minimum the options must include:

• Sort by patient name.

• Sort by date.

• Sort by test.

• Sort by incomplete test. Incomplete tests must have an indication of the pending time until completion.

Alert messages, or other notification, must be generated when testing is delayed beyond published timeframes.

Reports of test results must be immediately available upon verification of the test result.

Contractor’s computer located at the Government site must be able to print test results upon request and reprint retrospective test results.

Telecommunication Interface Requirements

For contract performance to begin within the shortest time possible after contract award, Contractor must already possess a current, VA nationally approved Business Partner Gateway (BPG) Interconnection Security Agreement (ISA) and Memorandum of Understanding (MOU) and have an integrated system approach to facilitate and streamline all aspects of specimen ordering, testing, and reporting. As such, the Contractor shall develop and program an interface connection to electronically transmit orders, specimen status, and test results between the Contractor’s host computer system and the Government’s host computer system (VistA).

The VistA host computer system supports a Universal Interface (UI) and a Generic Instrument Manager (GIM). The GIM is a commercial hardware and software product that provides electronic connection between the Contractor’s host computer and the Government’s host computer. The configuration must provide the required security of the Government host computer system. The actual electronic connection between the GIM and the Contractor’s host system is of the Contractor’s choosing. The initial and continual expense of the electronic message connectivity and maintenance shall be borne by the Contractor throughout the performance of the contract.

Contractor shall provide, install, maintain, repair, and if necessary, remove, all required telecommunication equipment, hardware, software, and related consumable supplies to support the transmission of electronic data to all sites referred to in Section B2. This may include, but is not limited to:

• Generic Instrument Manager (GIM) for the interface connection

• Shipping list printers

• Bar-code printers

• Back-up result printers connected directly to Contractor’s computer system

• Any required communication lines

• Software to receive and send orders, display status of and/or test results

• Consumable supplies to maintain the operation of the equipment listed above, e.g., toner/ink, paper, labels, etc.

Contractor shall be responsible for all annual recurring costs associated with support and maintenance of the Generic Instrument Manager (GIM) system including all GIM equipment, software, and instrument connections. The Generic Instrument Manager will be located in a government secured area. The Contractor shall coordinate with the respective Government Information Technology Department to access the GIM.

The Contractor shall conduct preventive maintenance and repair of Contractor furnished hardware, software, and associated communication lines. In addition, throughout the performance period of the contract, the Contractor shall repair or replace any malfunctioning hardware or software.

All electronic messaging between the two (Contractor and Government) host computer systems using the GIM shall utilize VistA Health Level Seven (HL7) V1.6 technical specifications. Health Level 7 (HL7) is a registered trademark of Health Level Seven, Inc, a Standards Developing Organization accredited by the American National Standards Institute to author consensus-based standards. Information regarding HL7 transmission protocols may be accessed through the Health Level Seven, Inc website, www.HL7.org.

VistA Laboratory Electronic Data Interchange (LEDI) identifies Government-specific content and encoding tables to be used with HL7 message protocol conventions. The LEDI specification follows very closely the HL7 V2.3.1 standard. LEDI identifies encoding tables and HL7 message protocol conventions.

LEDI also identifies to the commercial reference laboratory contractor shipping lists containing required specimen demographics and requested tests to be performed. This list will be provided in printed format during the implementation period. This information is also available in electronic HL7 format if required.

(LEDI) software will provide a HL7 acknowledgement for the receipt of tests results from the contractor. If electronic communication is disrupted, the contractor shall provide hard copy of specimen results upon demand. The hard copy must contain Government’s assigned specimen identification where specimen identification is defined as a unique Government-assigned number that is associated with each specimen. This specimen identification number will appear on the test order form, on the specimen label and on the shipping manifest.

The Contractor shall provide the Government with specimen status in response to electronic and verbal query. Upon test completion, a formatted HL7 message containing specimen test results with Government’s assigned specimen identification shall be returned to the requesting medical center.

Contractor shall address within two hours of initial inquiry, interface connection questions where http://www.hl7.org/ information is required to update, maintain, and support the services of the host-to-host linkage between the Government and the Contractor.

Contractor shall provide in-service training required for the routine loading and care of printers and other hardware located on-site. The training will ensure that Government staff can perform routine servicing of hardware.

4. Performance Monitoring The tasks are well defined and can, therefore, be easily monitored by the Government point of contact (POC), who shall represent the government for this process. The contractor performance will be monitored, and the work certified by the POC. The reference lab is required to obtain regulatory accreditation. Therefore, lab testing quality assurance is monitored by an independent third party. The reference lab will provide proof of current accreditation upon request.

5. Security Requirements The contractor must have and maintain accreditation as a healthcare provider to include compliance with the Health Insurance Portability and Accountability Act (HIPPA) of 1996 to ensure all Personal Health Information (PHI) is safeguarded from unauthorized disclosure. All test results will be reported to Sacramento VAMC via fax, email, or contractor’s online portal.

6. Inspection and Acceptance Criteria The POC is responsible for certifying that the work done under this contract is performed to standard.

The POC is also responsible to assure the inspection and acceptance of products provided incidental to services.

7. Place of Performance All work shall be performed at the contracted reference lab.

8. Business Hours / Days:

Are defined as the time of 8:00AM to 5:00PM, Monday through Friday, excluding Federal holidays:

New Year's Day January 1 * Martin Luther King's Day Third Monday in January President's Day Third Monday in February Memorial Day Last Monday in May Juneteenth National Independence Day June 19* Independence Day July 4* Labor Day First Monday in September Columbus Day Second Monday in October Veteran's Day November 11 Thanksgiving Day Fourth Thursday in November Christmas Day December 25*

*If the date falls on a Saturday, the Government holiday is the preceding Friday. If the date falls on a Sunday, the Government holiday is the following Monday.

In addition to the designated holidays, the Government observes the following days:

Any other day designated by Federal Statute Any other day designated by Executive Order Any other day designated by the President's Proclamation Off Business Hours/Days are defined as the time of 5:01PM to 7:59AM, Monday through Friday, all day Saturday, Sunday, and Federal holidays.

PERIOD OF PERFORMANCE:

Base Period: 4/1/2025 through 03/31/2025 Option Period One: 4/1/2026 through 03/31/2026 Option Period Two: 4/1/2027 through 03/31/2027 Option Period Three: 4/1/2028 through 03/31/2028 Option Period Four: 4/1/2029 through 03/31/2029

Federal Holidays

While not generally required to provide transportation of specimens and specimen processors on federal holidays there is a possibility that these services could be required.

HHS/OIG

To ensure that the individuals providing services under the Contract have not engaged in fraud or abuse regarding Sections 1128 and 1128A of the Social Security Act regarding federal health care programs, the contractor is required to check the Health and Human Services - Office of Inspector General (HHS/OIG), List of Excluded Individuals/Entities on the OIG Website (https://exclusions.oig.hhs.gov/) for each person providing services under this contract. Any healthcare provider or entity that employs or enters into contracts with excluded individuals or entities may have a Civil Monetary Penalty (CMP) imposed against them. By signing the contract, the Contractor is certifying that all persons performing services under the contract have been compared against the OIG list and are NOT listed as of the date the contract was signed.

Record Keeping – Contractor

Contractor must establish a record keeping system of all tests performed per regulatory guidelines.

HIPAA Compliance Contractor must adhere to the provisions of Public Law 104-191, Health Insurance Portability and Accountability Act (HIPAA) of 1996 and the National Standards to Protect the Privacy and Security of Protected Health Information (PHI). As required by HIPAA, the Department of Health, and Human Services (HHS) has promulgated rules governing the security and use and disclosure of protected health information by covered entities, including the Department of Veterans Affairs. The VA has recognized Diagnostic Laboratory Testing Facilities as healthcare providers, and that the PHI is being disclosed and/or used for treatment. Therefore, no BAA is required for Reference Laboratory Testing Services.

Regulatory Standard

All work under this contract shall be performed in accordance with all regulatory requirements for laboratory services such as those set forth by the Clinical Laboratory Improvement Amendments of 1988 (CLIA), as well as all other applicable laws and regulations.

As the VA facilities are a hospital setting, they are subject to inspections and accreditation by The Joint Commission. Contractor shall be aware of all laboratory standards required by The Joint Commission and, in the absence of a contradictory standard from another entity such as CLIA, all work under this contract shall be performed in accordance with those standards. A copy of these standards may be obtained from The Joint Commission, One Renaissance Blvd., Oakbrook Terrace, IL 60181.

Designation of Contracting Officer Representative (COR)

The VANCHCS Pathology & Laboratory Medicine Services (P&LMS) Manager will be designated as the COR to represent the Contracting Officer in furnishing guidance and advice regarding the work being performed under this contract. The COR will provide technical guidance, verify services were actually performed, and also verify that documentation for services performed is received prior to certifying payment. The foregoing is not to be construed as authorization to interpret or furnish advice and information to the Contractor relative to the financial or legal aspects of the contract.

Enforcement of these segments is vested in and is the responsibility of the Contracting Officer. The extent and limitations of the COR designation are provided in the COR Delegation Memo.

Contract Performance Monitoring

For specimen pickup, contractor employees shall report to the Laboratory for specimen pickup.

Monitoring of contractor’s performance shall be demonstrated through clinical and administrative record reviews. The COR will be responsible for verifying contract compliance and may designate other VANCHCS lab personnel to monitor services through one or a combination of the following mechanisms:

Departments being served will monitor Contractor performance to ensure that services called for in the contract have been received in a timely manner. Any incidents of Contractor noncompliance as evidenced by the monitoring procedures will be forwarded immediately to the Contracting Officer.

Documentation of services performed will be reviewed prior to certifying payment. VANCHCS will pay only for services provided, and in strict accordance with the Price schedule aka test menu /Attachment A. Contract monitoring and recordkeeping procedures shall be sufficient to ensure proper payment and allow audit verification that services were provided. The COR must provide written approval for payment of all invoices.

Facilities being served, through the COR, will provide a written statement to the Contracting Officer to include a summary of Contractor actions and a statement that all requirements of the contract have been fulfilled as agreed. This summary evaluation should be submitted 45 days prior to end of completion of the base and each option period.

Quality Assurance Monitoring

Contractor shall maintain a Quality Assurance Program related to the Reference Laboratory Testing Services covered under this contract.

Contractor shall also participate in a joint quality assurance surveillance program (QASP) with the VANCHCS P&LMS. This program must minimally address the quality aspects representative to the testing process, i.e., pre-analytical, analytical, and post-analytical variables and include a description of monitoring and evaluation activities. There must be a mutually agreed upon procedure for responding to issues, problems and/or concerns identified by the Government with details as to whom and in what timeframe the matters will be reconciled. The issues that may need to be addressed may be general in nature or specific to an incident or event. The contractor will meet or communicate with the facility staff for process review and improvement of contract performance on an as needed basis.

Copies of licensure/certifications are also required to be submitted upon request by the VANCHCS

COR.

Quality factors that VANCHCS may consider when monitoring quality of care may include, but are not limited to, patient medical records, security/privacy, adverse event…